Skip to main content
Erschienen in: Abdominal Radiology 1/2013

01.02.2013

Dynamic enhancing vascular pattern of intrahepatic peripheral cholangiocarcinoma on contrast-enhanced ultrasound: the influence of chronic hepatitis and cirrhosis

verfasst von: Rui Li, Xiaohang Zhang, Kuan-Sheng Ma, Xiao-Wu Li, Feng Xia, Hua Zhong, Chun-lin Tang, Yanli Guo, Xiao-Chu Yan

Erschienen in: Abdominal Radiology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To analyse the dynamic enhancing features by real-time contrast-enhanced ultrasound (CEUS) of intrahepatic peripheral cholangiocarcinoma (ICC) in patients with chronic hepatitis and cirrhosis.

Materials and methods

CEUS was performed by using contrast pulse sequencing (CPS) imaging with mechanical index of <0.2 after injection of 2.4 mL of contrast agent. CEUS images of histologically confirmed ICC in 54 patents (15 patents with chronic hepatitis B, 16 patents with cirrhosis, and 23 patents with normal underlying liver) were analyzed.

Results

Heterogeneous hyperenhancement was more frequently identified in ICC with chronic hepatitis (9 of 15, 60.0%, p = 0.000) and cirrhosis (8 of 16, 50.0%, p = 0.010) than in patients with normal liver (6 of 23, 26.1%) during arterial phase. The majority of ICC in patients with normal liver displayed peripheral hyperenhancement (13 of 23, 56.5%), than in patients with chronic hepatitis (4 of 15, 26.7%, p = 0.000) and cirrhosis (5 of 16, 31.3%, p = 0.001). Intense contrast uptake during the arterial phase (heterogeneous hyperenhancement or global hyperenhancement) followed by washout in venous phases was more frequently displayed in ICC patients with chronic hepatitis (11 of 15, 73.3%, p = 0.000) and in patients with cirrhosis (11 of 16, 68.8%, p = 0.000) than in ICC patients with normal underlying liver (8 of 23, 34.8%).

Conclusion

The enhancing vascular pattern of ICC on CEUS in patients with chronic hepatitis and cirrhosis is different from that in ICC without underlying liver disease. The enhancing vascular pattern is indistinguishable from HCC on CEUS in most ICC patients with chronic hepatitis or cirrhosis.
Literatur
1.
Zurück zum Zitat Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314PubMedCrossRef Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314PubMedCrossRef
2.
Zurück zum Zitat Shaib Y, El-Serag H (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–125PubMedCrossRef Shaib Y, El-Serag H (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–125PubMedCrossRef
3.
Zurück zum Zitat Davila JA, El-Serag HB (2002) Cholangiocarcinoma: the “other” liver cancer on the rise. Am J Gastroenterol 97:3199–3200PubMed Davila JA, El-Serag HB (2002) Cholangiocarcinoma: the “other” liver cancer on the rise. Am J Gastroenterol 97:3199–3200PubMed
4.
Zurück zum Zitat Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48:308–321PubMedCrossRef Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48:308–321PubMedCrossRef
5.
Zurück zum Zitat Shaib YH, El-Serag HB, Nooka AK, et al. (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case–control study. Am J Gastroenterol 102:1016–1021PubMedCrossRef Shaib YH, El-Serag HB, Nooka AK, et al. (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case–control study. Am J Gastroenterol 102:1016–1021PubMedCrossRef
6.
Zurück zum Zitat Khan SA, Davidson BR, Goldin R, et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(Suppl 6):vi1–vi9PubMedCrossRef Khan SA, Davidson BR, Goldin R, et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(Suppl 6):vi1–vi9PubMedCrossRef
7.
Zurück zum Zitat Chen LD, Xu HX, Xie XY, et al. (2008) Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 81:881–889PubMedCrossRef Chen LD, Xu HX, Xie XY, et al. (2008) Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 81:881–889PubMedCrossRef
8.
Zurück zum Zitat D’Onofrio M, Vecchiato F, Cantisani V, et al. (2008) Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging. Radiol Med 113:76–86PubMedCrossRef D’Onofrio M, Vecchiato F, Cantisani V, et al. (2008) Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging. Radiol Med 113:76–86PubMedCrossRef
9.
Zurück zum Zitat Li R, Guo Y, Hua X, et al. (2007) Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound 35:109–117PubMedCrossRef Li R, Guo Y, Hua X, et al. (2007) Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound 35:109–117PubMedCrossRef
10.
Zurück zum Zitat Celli N, Gaiani S, Piscaglia F, et al. (2007) Characterization of focal liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 19:3–14PubMedCrossRef Celli N, Gaiani S, Piscaglia F, et al. (2007) Characterization of focal liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 19:3–14PubMedCrossRef
11.
Zurück zum Zitat Xu HX, Liu GJ, Lu MD, et al. (2006) Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 34:261–272PubMedCrossRef Xu HX, Liu GJ, Lu MD, et al. (2006) Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 34:261–272PubMedCrossRef
12.
Zurück zum Zitat Xu HX, Lu MD, Liu GJ, et al. (2006) Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 25:23–33PubMed Xu HX, Lu MD, Liu GJ, et al. (2006) Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 25:23–33PubMed
13.
Zurück zum Zitat Vilana R, Forner A, Bianchi L, et al. (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51:2020–2029PubMedCrossRef Vilana R, Forner A, Bianchi L, et al. (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51:2020–2029PubMedCrossRef
14.
Zurück zum Zitat Wilson SR, Kim TK, Jang H-J, Burns PN (2007) Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 189:W7–W12PubMedCrossRef Wilson SR, Kim TK, Jang H-J, Burns PN (2007) Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 189:W7–W12PubMedCrossRef
15.
Zurück zum Zitat Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34PubMedCrossRef Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34PubMedCrossRef
16.
Zurück zum Zitat Lok ASF, Mcmahon BJ (2007) AASLD practice guideline chronic hepatitis B. Hepatology 45:507–539PubMedCrossRef Lok ASF, Mcmahon BJ (2007) AASLD practice guideline chronic hepatitis B. Hepatology 45:507–539PubMedCrossRef
17.
Zurück zum Zitat Poultsides GA, Zhu AX, Choti MA, Pawlik TM (2010) Intrahepatic cholangiocarcinoma. Surg Clin N Am 90:817–837PubMedCrossRef Poultsides GA, Zhu AX, Choti MA, Pawlik TM (2010) Intrahepatic cholangiocarcinoma. Surg Clin N Am 90:817–837PubMedCrossRef
18.
Zurück zum Zitat Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. AASLD practice guideline. Hepatology 42:1208–1236PubMedCrossRef Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. AASLD practice guideline. Hepatology 42:1208–1236PubMedCrossRef
19.
Zurück zum Zitat Quaia E, Calliada F, Bertolotto M, et al. (2004) Characterization of focal liver lesions with contrast specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420PubMedCrossRef Quaia E, Calliada F, Bertolotto M, et al. (2004) Characterization of focal liver lesions with contrast specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420PubMedCrossRef
20.
Zurück zum Zitat Catala V, Nicolau C, Vilana R, et al. (2007) Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 17:1066–1073PubMedCrossRef Catala V, Nicolau C, Vilana R, et al. (2007) Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 17:1066–1073PubMedCrossRef
21.
Zurück zum Zitat Celli N, Gaiani S, Piscaglia F, et al. (2007) Characterization of focal liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 19:3–14PubMedCrossRef Celli N, Gaiani S, Piscaglia F, et al. (2007) Characterization of focal liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 19:3–14PubMedCrossRef
22.
Zurück zum Zitat Claudon M, Cosgrove D, Albrecht T et al. (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)—update 2008. Ultrschall in Med 29:28–44CrossRef Claudon M, Cosgrove D, Albrecht T et al. (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)—update 2008. Ultrschall in Med 29:28–44CrossRef
23.
Zurück zum Zitat Beaton C, Cochlin D, Kumar N (2010) Contrast-enhanced ultrasound should be the initial radiological investigation to characterize focal liver lesions. Eur J Surg Oncol 36:43–46PubMedCrossRef Beaton C, Cochlin D, Kumar N (2010) Contrast-enhanced ultrasound should be the initial radiological investigation to characterize focal liver lesions. Eur J Surg Oncol 36:43–46PubMedCrossRef
24.
Zurück zum Zitat Lencioni R, Piscalia F, Bolondi L (2008) Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol 48:848–857PubMedCrossRef Lencioni R, Piscalia F, Bolondi L (2008) Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol 48:848–857PubMedCrossRef
Metadaten
Titel
Dynamic enhancing vascular pattern of intrahepatic peripheral cholangiocarcinoma on contrast-enhanced ultrasound: the influence of chronic hepatitis and cirrhosis
verfasst von
Rui Li
Xiaohang Zhang
Kuan-Sheng Ma
Xiao-Wu Li
Feng Xia
Hua Zhong
Chun-lin Tang
Yanli Guo
Xiao-Chu Yan
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Abdominal Radiology / Ausgabe 1/2013
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-012-9854-x

Weitere Artikel der Ausgabe 1/2013

Abdominal Radiology 1/2013 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.